Produced By Global Insight Conferences – 14 Years of Unquestionable Quality

Practical, Proven & Proactive New Strategies To Empower The Patient Voice & Boost Patient Outcomes With

Strategic, Meaningful & Value-Driven Insights Which Maximise Patient Centricity, Elevate Engagement & Strengthen Collaboration

A One-Day, Practitioner-Led Conference & Networking Exhibition | Amsterdam | 13th November 2024

08.30

REGISTRATION OPENS

Registration, Speed Networking & GIC Welcome

09.00

OPENING REMARKS

Morning Chair’s Opening Remarks

Jost Leehuis MD, Safety Science Partner, Roche

09.10

PANEL Q&A

END-TO-END PATIENT ENGAGEMENT

Successfully Embed Patient-First Strategies & Foster Transparent Relationships That Integrate Patients Into All Healthcare Processes & Fuel Purposeful Change Across Multiple Healthcare Systems

●  What strategies and approaches have made a real and tangible impact in patient engagement? Assess current methods, emerging strategies, and critical feedback on patient experiences to ultimately provide better patient journeys, treatment, and care

●  Amplify the importance of early communication and collaboration with patients for more efficient drug development cycles that reduce impact on patients and improve market access

●  Develop high-impact communication strategies to cultivate interactions with patients that help to decipher the hard-to-navigate healthcare regulations for medicines and devices that guarantee commercial success

●  Reduce drug development red tape, identify gaps, and produce treatments that authentically support patient needs throughout the entire patient journey by ensuring patient centricity is at the forefront of development processes

Katja Cramer, Sci. Head Patient Engagement & Advocacy Germany, Janssen – Pharmaceutical Companies of Johnson & Johnson

Jasenka Tiefenbach, Value-Based Partnership & Innovative Patient Solution Lead, Takeda Eastern Europe

Helene Riveiro, Global Medical Associate Director Dermatology – Global Medical Affairs, Sanofi

Carrie Sacks, Innovation Manager, Novartis

09.40

MEASURE WITH PURPOSE

DATA, MEASUREMENT & METRICS

Maximise The Value Of Patient Engagement & Deliver Actionable Strategies With Measurement & Benchmarking Tools & Metrics Which Translate Patient Experience Data Insights Into Tangible Results

●  Develop clear metrics to optimise patient engagement strategies by utilising patient evidence and complementing clinical data to advocate for better health outcomes

●  Patient-powered data: how can you utilise patient experience data to uplift the patient voice, leverage key KPIs, and embed this into regulatory decision making?

●  Harness real-world strategies for measuring outcomes to pinpoint realistic measurable outcomes which reduce impact on patients and improve market access

Behtash Bahador, Director – Health Literacy, CISCRP

10.00

DOUBLE PERSPECTIVE

PATIENT-CENTRIC DECISION MAKING

Drive Change By Advocating For The Value Of Patient Voice In Key Processes & Decision Making To Encourage Global & Patient-Led Industry Transformation

●  Embed patient-centred decision-making in drug development by focusing the paramount importance of patient voices in broader industry contexts

●  Elevate patients to strategic partners by highlighting their essential role in addressing barriers to patient centricity and improving patient outcomes

●  How can pharma and healthcare professionals engrain patient-centricity into advocacy models and ensure equity in patient market access globally and locally?

10.00 Perspective 1

Shannon Altimari, Senior Director – Patient Engagement & Global Oncology Lead, GSK

10.20 Perspective 2

Carole Scrafton, CEO & Co-Founder, Flutters & Strutters

10.40

BONUS SESSION; RESERVED FOR EXCLUSIVE CONFERENCE PARTNER

11.10

MORNING REFRESHMENT BREAK WITH INFORMAL NETWORKING

11.40

PATIENT ENGAGEMENT IN HTAS

Accelerate The Effectiveness Of Health Technology Assessment Processes By Advocating For Increased Patient Involvement To Comprehensively Assess & Address Limits To Global Market Access

●  Debate the need for patient inclusion in the HTA framework – why is patient voice critical at this stage and what are the potential outcomes?

●  Securely enable patients and patient advocacy groups to better understand and participate in the health technology assessment framework to accelerate patient education around future drug development

●  How can you leverage patient experience data to improve HTA processes for greater impact?

Mignon Van der Westerlakan, Head Public Affairs & Communication NL, Sanofi

12.00

CASE STUDY

EXCLUSIVE INSIGHTS – BIOGEN CASE STUDY

Navigating Business Demands Whilst Upholding A Dedication To Patient Engagement

Natacha Raphael, Former International Head- Corporate Affairs & Patient Advocacy, Biogen

12.20

PANEL Q&A 

MEANINGFUL STAKEHOLDER COLLABORATION

Successfully Connect All Key Stakeholders & Secure Value-Driven Collaborations By Aligning Visions & Values To Strengthen Patient Outcomes & Maximise Commercial ROI

●  Support a global network of cross-functional patient engagement stakeholders to optimise access programs and services, innovations, and educational materials to support patients at every level

●  How can you effectively engage senior leadership to guarantee long-term support for your patient engagement goals and prioritise the best care and experience for patients whilst remaining commercially successful?

●  Discuss complex conflicts of interest among patients, advocacy groups, healthcare providers, and compliance agencies to better align and incorporate preferences into emerging drug development and commercialisation strategies

●  Collaboration is key! Build meaningful relationships within the industry and include advocacy groups, healthcare experts, researchers, carers, and patients in your network to gain practical strategies to combat barriers to patient centricity

Konstantinos Tsekmes, Associate Director Clinical Operations, MSD

Nicolas Pivert, Senior Business Director Cardiac Pacing Therapies – Western Europe, Medtronic

Marija Koumoutsaris, Director Medical Safety Team Lead Global Patient Safety, Sandoz

Arun Micheelson, Senior Specialist – Patient Insights, Lundbeck

Nikul Baksho, Research Involvement Lead, Parkinsons UK

12.50

PATIENT-CENTRIC CLINICAL TRIALS

Develop & Progress Purposeful Partnerships With Patients To Optimise Clinical Trial Design Encourage Global Patient Access & Secure Patient-Approved Therapies

●  Discuss the benefits of patient involvement in the design and preparation phase of clinical trials and showcase the value of engaging and communicating with patients at the very start

●  What happens when patients don’t fit the perfect patient mould? Prioritise patient diversity strategies for clinical trials that reach unrepresented groups for equitable and inclusive patient outcomes

●  Which opportunities increase patient participation for collaborative interactions during the clinical trial design to boost patient access in real life

●  Debate global approaches to clinical trial design, pinpoint gaps for improvement, and ensure patient’s input to improve efficacy safety and quality of drug development is at the centre of your business plan

Marta Garcia Manrique, R&D – Chief Patient Officer, Servier

13.10

BONUS SESSION; RESERVED FOR EXCLUSIVE CONFERENCE PARTNER

13.30

LUNCH & INFORMAL NETWORKING FOR SPEAKERS, DELEGATES & PARTNERS

14.00

INFORMAL BREAKOUT DISCUSSIONS

a) Rare Diseases & Uplifting The Rare Community

Lex van der Heijden, PMP, Prince 2, President, CMTC-OVM

b) Patient Education & Research

Wendy Borsari, Associate Director- Patient Advocacy, Tenaya Therapeutics

c) Patient & Pharma Co-Creation

14.30

Afternoon Chair’s Opening Remarks

Natacha Raphael, Former International Head – Corporate Affairs & Patient Advocacy, Biogen

14.40

AI, DIGITAL, TECH & TOOLS

DIGITAL ENGAGEMENT

Effectively Engage Patients Across Both Physical & Digital Spaces By Leveraging AI & Automation Platforms & Tools To Deliver High-Impact Holistic Care  

●  Determine the most effective platforms to reach and engage with patients and improve patient outcomes

●  How are patients responding to digital change? Create robust strategies that measure the value of digital engagement to guarantee seamless user adoption in patient journeys

●  Co-create digital processes with patients and advocates to gauge the best practices to resonate with different patient audiences

●  How will regulatory updates affect digital access for patients and what measures can be taken to mitigate upcoming risks to optimal engagement?

Arun Micheelson, Senior Specialist – Patient Insights, Lundbeck

15.00

PANEL Q&A

PATIENT PERSPECTIVES & STORIES

Centre The Most Essential Stakeholder: The Patient! Empower & Engage Patients With Transparent Insights Into Personal Patient Experiences & Testimonies To Strengthen Relationships & Align Values & Goals

●  What are the topmost patient concerns of 2025 and beyond? Share insights into the pressures of everyday patients to amplify patient voice and tailor partnerships with patient advocacy groups to patient needs

●  Uncover new best practices in pharma-patient communications by hearing what has worked and what has not through real patient feedback to better align visions and values, achieving mutually desirable results

●  How can you support patients and sustain long-lasting relationships which promote patient involvement in collaborations?

Steve Clark, Patient Advocate Campaigns Ambassador, Patient Advocate

Alan Thomas, Founder & Chairman, Ataxia & Me

Lex van der Heijden, PMP, Prince2, President, CMTC-OVM

15.30

CASE STUDY

EXCLUSIVE INSIGHTS— PFIZER CASE STUDY

Personalising Platforms With Patient Experience: Pfizer’s This Is Living With Cancer (TLWC)

Ana Arboleda, Global Director Patient Experience- Oncology, Pfizer

15.50

BONUS SESSION; RESERVED FOR EXCLUSIVE CONFERENCE PARTNER

16.20

AFTERNOON REFRESHMENT BREAK WITH INFORMAL NETWORKING 

16.50

PATIENT JOURNEYS

Proactively Collaborate With Patients To Ensure Sustained Support Throughout Patient Journeys By Re-Evaluating Processes & Initiatives With Patients At The Centre Of Decision Making

●  Demonstrate the impact of patient voice by incorporating the needs of the patient and caregiver community into your organisation’s goals and values

●  How can you leverage insightful PAG data to co-create tailored patient journeys with specific disease advocacy groups for health outcomes?

●  Strategically empower the healthcare community towards patient-driven strategies to ensure best care practices

●  How can you initiate changes in relationships and structures to establish patient engagement as a business-wide priority?

16.50 Perspective 1

Jacek Lange MD PhD, Associate Director – Medical Affairs (Renal Care, Central & Southeast Europe & CIS), Baxter International Inc

17.10 Perspective 2

Wendy Borsari, Associate Director- Patient Advocacy, Tenaya

17.30

PANEL Q&A – Critical Strategies

OVERCOMING BARRIERS TO PATIENT CENTRICITY

Break Through Barriers To Patient Centricity & Engagement To Empower Patients, Achieve Industry-Wide Goals & Tackle Increased Regulatory Uncertainty

●  Drive purposeful patient engagement by strategising short-term and long-term solutions to overcoming critical barriers to support underserved patient communities

●  Be prepared and get ahead! Gauge impact of emerging regulations and initiatives and determine what makes the difference to drive greater patient involvement within regulation compliance

●  How can pharmaceutical companies empower patient advocacy groups and ensure sustainable PAG involvement in 2025 and beyond?

Jacek Lange MD PhD, Associate Director – Medical Affairs (Renal Care, Central & Southeast Europe & CIS), Baxter International Inc

Dr Lorna Pender, Global Patient Engagement Lead, Clinigen

Jolanda Koenders, Head of New Product Planning Central Southeast Europe, Takeda

18.00

CLOSING REMARKS

Afternoon Chair’s Closing Remarks & Official Close Of Conference

Natacha Raphael, Former International Head – Corporate Affairs & Patient Advocacy, Biogen

Don't Miss Out!

Book Before Thursday & Save £170!